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The invasive tumor front (the tumor–host interface) is vitally important in malignant
cell progression and metastasis. Tumor cell interactions with resident and infiltrating
host cells and with the surrounding extracellular matrix and secreted factors ultimately
determine the fate of the tumor. Herein we focus on the invasive tumor front,
making an in-depth characterization of reticular fiber scaffolding, infiltrating immune
cells, gene expression, and epigenetic profiles of classified aggressive primary uterine
adenocarcinomas (24 patients) and leiomyosarcomas (11 patients). Sections of formalin-
fixed samples before and after microdissection were scanned and studied. Reticular
fiber architecture and immune cell infiltration were analyzed by automatized algorithms
in colocalized regions of interest. Despite morphometric resemblance between reticular
fibers and high presence of macrophages, we found some variance in other immune
cell populations and distinctive gene expression and cell adhesion-related methylation
signatures. Although no evident overall differences in immune response were detected
at the gene expression and methylation level, impaired antimicrobial humoral response
might be involved in uterine leiomyosarcoma spread. Similarities found at the invasive
tumor front of uterine adenocarcinomas and leiomyosarcomas could facilitate the
use of common biomarkers and therapies. Furthermore, molecular and architectural
characterization of the invasive front of uterine malignancies may provide additional
prognostic information beyond established prognostic factors.
Keywords: tumor-host interface, tumor microenvironment, extracellular matrix, reticular fibers, immune cells,
gene expression, epigenetic profiles
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INTRODUCTION
Uterine endometrial adenocarcinoma (uADC) is the fourth most
common cancer among women in the Western world, with an
estimated incidence of 10–20 per 100,000 women. Although
prognosis is favorable for patients identified with low-grade
tumors and early-stage disease, outcomes for patients with high-
grade and metastatic/recurrent tumors remain poor (Ferlay
et al., 2010) and represent a therapeutic challenge. The World
Health Organization (WHO) tumor classification distinguishes
several histopathological types of uADC, particularly based on
microscopic appearance (Cree et al., 2020): (1) endometrioid
carcinoma, low grade (grades I–II) or high grade (grade III),
(2) serous carcinoma, (3) clear cell carcinoma, (4) mixed
carcinoma, (5) undifferentiated carcinoma, (6) carcinosarcoma,
(7) neuroendocrine carcinomas, and (8) other unusual types.
These types have different histological and molecular features,
precursor lesions, and natural history (Matias-guiu et al., 2001;
Yeramian et al., 2013). They are also stratified by Tumor Cancer
Genome Atlas (TCGA)-based molecular classification into four
risk groups combining gene encoding DNA polymerase ε (POLE)
mutational analysis with IHC analysis of p53 and mismatch
repair (MMR) proteins (PMS-2 and MSH-6) (Getz et al., 2013).
This provides additional prognostic information to complement
the microscopic features.
Uterine leiomyosarcoma (uLMS) accounts for 1% of all
uterine malignancies, with an annual incidence rate of 0.4–0.9
per 100,000 women. Like other forms of sarcoma, uLMS spreads
to other parts of the body via the bloodstream rather than the
lymphatic system. Although rare, this cancer can be extremely
aggressive and is known to be generally unresponsive to
radiation or chemotherapy. Patient survival is highly dependent
on speed of diagnosis and treatment, falling to 14% at
5 years post-diagnosis for metastatic uLMS. From a molecular
viewpoint, uLMS contains complex karyotypes, with numerous
chromosomal aberrations and frequent deletions affecting
chromosomal arms 2p, 2q, 10q, and 13q, as well as amplifications
on 1p, 5q, and 8q, and precise alterations in TP53, RB1, PTEN,
MED12, YWHAE, and VIPR2 (Cuppens et al., 2018).
There is growing interest in understanding the molecular
features involved in myometrial invasion, a highly valuable
parameter due to its direct association with poor prognosis
and limited therapeutic response in uADC and uLMS. From
a histopathological perspective, a variety of invasion patterns
frequently coexist in different areas of the same tumor (Euscher
et al., 2013). Moreover, several tumor types show specific invasion
patterns not seen in other types of cancer. These differences can
be explained by the fact that cancer cell invasion is currently
viewed as an adaptive and heterogeneous process (Friedl and
Alexander, 2011) involving key processes such as cytoskeleton
dynamics, cell adhesion plasticity, and mechanotransduction of
external stimuli.
Type-specific new stroma generated at the site of active
tumor invasion, the invasive tumor front (ITF), is crucial in
tumor growth and invasion processes (Provenzano et al., 2006;
Giatromanolaki et al., 2007). In fact, high proliferation rates
and cell cycle derailment have been shown at the ITF in uADC
(Horrée et al., 2007). Structures surrounding tumors such as
mature collagen and smooth or striated muscle can act as a
barrier to tumor invasion, as shown by collagen organization
at the ITF of oral squamous cell carcinomas (Devendra et al.,
2018). However, tumor cells can disrupt the continuity of such
structures by remodeling the immediate stroma of the tumor
to carve out paths for invasion. Indeed, invasive tumor growth
in pancreatic ductal adenocarcinoma is mediated via matrix
remodeling metalloproteinases (Croft et al., 2004; Rath et al.,
2017). Changes in the fibrillar pattern of adjacent stroma of
tumor tissues have been also observed in skin tumor (Stenbäck
et al., 1999), oral squamous cell carcinoma, and lymph nodes
with metastasis, among others (Yinti et al., 2015; Kardam et al.,
2016). In fact, the tumor-derived extracellular matrix (ECM)
is biochemically distinct in its composition and is stiffer than
normal ECM. This new associated ECM compartment, rich in
cross-linked collagen III (reticular fibers), has been proposed as a
prospective marker of early stromal invasion in incipient tumors
such as breast cancer (Sivridis et al., 2004; Acerbi et al., 2015).
In addition, not only the ECM collagen composition but also
the orientation of the fibers have been proposed as a prognostic
signature for survival in breast cancer (Conklin et al., 2011;
Xi et al., 2021).
The complex interaction between heterogenic immune cell
subpopulations and tumor cells may drive tumor progression,
metastasis, and resistance to therapy (Galli et al., 2020). The
intensifying development of immunotherapeutic strategies calls
for a better understanding of tumor-immune subpopulation
interactions and spatial distribution at the ITF (Blomberg et al.,
2018; König et al., 2019). In this context, the use of a multiplex
immunolabeling panel is essential as it enables different cell
subpopulations to be identified in one tissue section (Gorris et al.,
2018). Multiplexed analysis can also simultaneously measure
the expression of distinct markers in a single cell as well
as spatial associations between immune cell subpopulations.
We applied this technology to evaluate the complex immune
environment of the ITF of uADC and uLMS. A previously
developed and validated multiplex immunolabeling panel was
used to simultaneously assess the phagocytic cell marker CD68
of macrophages, CD3 + and CD8 + T cells, and CD20 + B
lymphocytes in a single FFPE tissue (Abengozar-Muela et al.,
2020; Salas-Benito et al., 2021).
Changes in activated-leukocyte cell adhesion molecule
(ALCAM) expression at the endometrial tumoral cell surface
(Devis et al., 2018) and increased expression of cytoplasmic
Cyclin D1 (Fusté et al., 2016) have been reported to allow
dissemination and invasion of endometrial neoplastic cells.
Epigenetic mechanisms play an important role in regulating
gene expression during many biological processes (Sharma et al.,
2009). DNA methylation is the most widely studied epigenetic
modification, produced by adding a methyl group (CH3) to
the 5’ carbon of cytosines in cytosine–phosphate–guanine
(CpG) dinucleotides to generate 5-methylcytosine (5mC)
(Bao-Caamano et al., 2020). Deregulation of this epigenetic
mechanism has major implications for cancer development and
progression (Diaz-Lagares et al., 2016). In this context, recent
genome-wide analyses have revealed striking alterations in the
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methylation profile of uterine uADC and uLMS (Zhang et al.,
2014; Kommoss et al., 2020; Vargas et al., 2021).
Cancers show a clear coevolution between tumor cells
and the tumor microenvironment. Specific differences in the
tumor microenvironment at different locations may play a
role in tumor growth, metastatic progression, and therapy
responses (Oliver et al., 2018; Zhang and Yu, 2019). In fact,
tumor invasion is a dynamic process facilitated by bidirectional
interactions between tumor cells and the microenvironment,
being particularly intense at the ITF. Unlike tumor cells,
tumor microenvironment elements are genetically stable and
thus represent an attractive therapeutic target. Uterine uLMS
and uADC are different tumor types occurring in the same
organ, both of which infiltrate the myometrium during local
progression. The main objective of the present study is to
analyze several aspects of microenvironment response at the
ITF in these two tumor types, looking for similarities and
differences that could provide insight into potential new common
therapeutic approaches, an aim that to our best knowledge has
not previously been addressed.
MATERIALS AND METHODS
Patients, Sample Description, and Case
Selection
A search for uADC and uLMS cases was conducted in the
study institutions. Selection criteria included available pathology
reports, representative sections of the ITF, histologically proven
distant metastasis, and acceptable pre-analytical conditions.
Cases were reviewed by a panel of expert gynecological
pathologists from the institutions involved. In total, 24 uADC
and 11 uLMS fulfilled all criteria and were included in the study.
The study used formalin-fixed and paraffin-embedded (FFPE)
tissue samples from 24 uADC and 11 uLMS obtained from
five Spanish hospitals (Hospital Clínico de Valencia; Hospital
Virgen del Rocio, Seville; Hospital Universitari Vall d’Hebron
and Hospital Universitari de Bellvitge, Barcelona; Hospital
Universitari Arnau de Vilanova, Lleida) and the Norwegian
Radium Hospital, Oslo University Hospital, Oslo, Norway.
Tumors were classified following the most recent WHO criteria
and were surgically staged and graded according to the
FIGO (International Federation of Gynecology and Obstetrics)
staging and grading systems. The study was approved by
the local research ethics committee, and specific informed
consent was obtained.
Whole slide FFPE tissue sections of 5 μm of selected uADC
and uLMS were stained with H&E (hematoxylin and eosin)
and examined by the centralized expert group of pathologists
to select the representative areas to include in the study. The
interface between tumor tissue and adjacent myometrium was
microdissected under the microscope. Microscopic images were
obtained using a digital slide scanner [Pannoramic 250 FLASH II
2.0 (3D Histec)].
All uADC were of endometrioid type and were classified
according to the Cancer Genome Atlas (TCGA) surrogate
(0% POLE mutated, 58.5% non-specific molecular profile, 29%
mismatch repair-deficient tumors, and 12.5% p53 abnormal). All
uLMS were conventional-type high-grade tumors.
Selection of Regions of Interest
Sections of FFPE tissue samples were scanned before and
after microdissection. Whole sections including the interface
between tumor tissue and adjacent myometrium areas (the
ITF) were used for morphometric analysis. ITF microdissected
tissue was employed for transcriptomic and epigenomic studies
(Supplementary Figure 1A). The amount of ITF microdissected
tissue varied from case to case, but the median width was 5 mm
(±1.66mm) andmedian length 15mm (±4.91mm). The amount
of tumor vs. myometrium is shown in Supplementary Table 1.
Serial uADC and uLMS whole slides were used for
histomorphometric analysis of reticular fibers and multiplex
immunofluorescence-based immune profiling. ITF regions
were identified in stained tissue (Gomori and multiplex
immunofluorescence) by extrapolation of previous H&E-
selected regions. A region of interest (ROI) of 5 × 4 mm for
each sample was identified within the ITF-stained area. These
5 × 4-mm regions were used to correlate the results between
genomic, epigenetic, and morphometric studies (Supplementary
Figure 1A). To achieve in-depth characterization of the reticular
fibers and immune infiltrate of the ITF, we further broke
down the 5 × 4-mm ROIs into 1-mm2 ROIs representing
the following categories: (a) tumor (uADC or uLMS with
absence of myometrium), (b) myometrium (excluding infiltrated
myometrium from the analysis), and (c) balanced representation
of the invasion front (containing 50% tumor and 50%
myometrium). Supplementary Figure 1 shows a schematic
representation of the procedure. Cases and ROIs where the
algorithm failed because of poor or excessive staining were
excluded from the analysis, as were samples with unsatisfactory
segmentation. The number of 5 × 4-mm and 1-mm2 ROIs of
each case in Gomori and multiplex immunofluorescence stained
tissue are shown in Supplementary Table 1.
Histomorphometric Analysis of Reticular
Fibers
The architecture of uADC and uLMS reticular fibers stained
using Gomori’s method was uncovered. All samples were
digitized with the whole-slide scanner Ventana iScan HT (Roche)
at 20 × with a resolution of 0.46 μm/pixel. We used the open-
source digital pathology software QuPath for sample visualization
and identification of ROIs (Bankhead et al., 2017). 5× 4-mm and
1-mm2 ROIs were exported to ImageJ (Schneider et al., 2012),
and these were saved as TIFF for image analysis.
In this study, we employed an advanced morphometric
methodology based on a probabilistic method for the automatic
segmentation of reticular fibers. We used Gomoripath, a
morphometric tool for easy segmentation of reticular fibers
developed by researchers from Incliva Biomedical Research
Institute/University of Valencia, University of Castilla La
Mancha, and the Andalucía Public Health System (Espinosa-
Aranda et al., 2016). Briefly, the algorithm is based on
nominal logistic regression applied to the optical density of
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the histopathological images. The optical density is calculated
iteratively, allowing reticular fibers to be enhanced. Subsequently,
a logit model is used to calculate the probability of each pixel
belonging to the structure of reticular fibers depending on their
topology, thus creating a probability map for the entire image.
The ROC (Receiver Operating Characteristic) curve generated by
the model finally obtained an AUC (area under the ROC curve)
of 0.9563 in reticular fiber detection.
Fifteen morphometric parameters defining the histological
organization of reticular fibers were calculated for each fiber
detected and the mean for each sample calculated. Morphometric
parameters were extracted to characterize the size and shape of
the morphometric variables at the ITF. In addition, the algorithm
measured the stained area of the tissue analyzed (excluding holes
and damaged tissue), allowing us to determine the number of
fibers per mm2 (density) and the percentage of fiber-stained area
(%SA) (taking into account the sum of the areas of all fibers).
Morphometric parameters defining the histological organization
of the reticular fiber networks have been explained elsewhere
(Tadeo et al., 2016). Themean of each parameter of similar uADC
and uLMS ROIs was calculated for comparison (Figures 1–3).
Multiplex Immunofluorescence Cell
Phenotype
We next sought to investigate the uADC and uLMS myeloid
and lymphocytic contexture in the FFPE tissue samples.
A multiplex immunofluorescence panel was used to enable
simultaneous examination of several cellular markers, including
the phagocytic cell marker CD68 of macrophages, CD3 + and
CD8 + T cells, and CD20 + B lymphocytes. Multiplex
immunofluorescence development and validation workflow and
protocols were implemented as previously described (Schalper
et al., 2019; Abengozar-Muela et al., 2020; Salas-Benito et al.,
2021). Briefly, 5-μm sections of FFPE tissue were deparaffinized
and antigen retrieval was performed using DAKO PT-Link
heat-induced antigen retrieval with low pH (pH 6) or high
pH (pH 9) target retrieval solution (DAKO). Each tissue
section was subjected to five successive rounds of antibody
staining, each round consisting of protein blocking with antibody
diluent/block (Akoya Biosciences ARD1001EA) and incubation
with a primary antibody, Opal Polymer anti-mouse/rabbit HRP
(Akoya Biosciences ARH1001EA), followed by tyramide signal
amplification (TSA) with Opal fluorophores (Akoya Biosciences)
diluted 1:100 in 1 × plus amplification diluent (Akoya
Biosciences FP1498). The myeloid and lymphoid cell panel
included CD68 (Mouse monoclonal, clone PG-M1, ready-to-
use, Agilent IR613), CD3 (Rabbit polyclonal, IgG, ready-to-use,
Agilent IR503), CD8 (Mouse monoclonal, clone C8/144B, ready-
to-use, Agilent IR623), CD20 (Mouse monoclonal, IgG2α, clone
L26, ready-to-use, Roche 760-2531), and cytokeratin (Mouse
monoclonal, clone AE1/AE3, diluted 1:100, Agilent M3515).
Finally, in the last round, nuclei were counterstained with spectral
DAPI (Akoya Biosciences FP1490) and sections mounted with
Faramount Aqueous Mounting Medium (Dako S3025).
Each whole-tissue section was scanned on a Vectra-
Polaris Automated Quantitative Pathology Imaging System
(Akoya Biosciences). Tissue imaging and spectral unmixing
were performed using InForm software (version 2.4.8, Akoya
Biosciences), as previously described (Abengozar-Muela et al.,
2020; Salas-Benito et al., 2021). Image analysis was performed
on 5 × 4-mm and 1-mm2 ROIs using the open-source digital
pathology software QuPath version 0.2.3, as previously described
(Abengozar-Muela et al., 2020). In short, cell segmentation
based on nuclear detection was performed on QuPath using
the StarDist 2D algorithm, a method that localizes nuclei
via star-convex polygons, incorporated into QuPath software
by scripting. A random-tree algorithm classifier was trained
separately for each cell marker by an experienced pathologist
annotating the tumor regions. Interactive feedback on cell
classification performance is provided during training in the
form of mark-up image, significantly improving the accuracy
of machine learning-based phenotyping (Bankhead et al., 2017;
Abengozar-Muela et al., 2020). All phenotyping and subsequent
quantifications were performed blinded to the sample identity.
Cells close to the border of the images were removed to reduce
the risk of artifacts. Based on the fluorescence panels, cells were
further subclassified as CD68+, CD3+, CD8+, and CD20+.
Cells negative for these markers were defined as other cell types.
The mean of the frequency of each cell marker of similar uADC
and uLMS ROIs was calculated for comparison (Figures 3, 4).
Transcriptomic Profiling
Total RNA for gene expression assays was prepared from 5-μm
FFPE tissue sections of microdissected ITF using the Agencourt
FormaPure kit (A33341; Beckman Coulter, Indianapolis, IN,
United States) and following the manufacturer’s instructions. The
RNA concentration was determined with Qubit 4 Fluorometer
and Qubit R© RNA HS Reagent (Thermo Fisher Scientific,
Waltham, MA, United States). RNA samples passing the quality
control evaluation (uADC n = 19, uLMS n = 11) were selected.
Transcriptomic profiling was performed with HTG EdgeSeq
Precision Immuno-Oncology Panel, which interrogates 1,392
genes involved in tumor/immune interaction1. HTG EdgeSeq
Chemistry was employed to synthetize the RNA-Seq library.
Briefly, target capture was performed by hybridizing the mRNA
with Nuclease Protection Probes (NPPs). The S1 nuclease was
added to the mix, producing a stoichiometric amount of target
mRNA/NPP duplexes. This reaction was blocked by enzyme
heat denaturation of S1. The samples were randomized before
inclusion in the HTG EdgeSeq system to reduce potential biases
in the run. Each hybridized sample was used as template to
set up PCR reactions with specially designed tags, sharing
common sequences that are complementary to both 5′-end and
3′-sequences of the probes, and common adaptors required
for cluster generation on an Illumina sequencing platform. In
addition, each tag contains a unique barcode used for sample
identification and multiplexing. After PCR amplification, a
cleanup procedure was performed using Agencourt AMPure XP
(Beckman Coulter). The library was quantified by quantitative
PCR, using KAPA Library Quantification (Roche), according
to the manufacturer’s instructions. All samples and controls
were quantified in triplicate, and no template control was
1https://www.htgmolecular.com/assets/htg/publications/GL-HTG-EdgeSeq-
Precision-Immuno-Oncology-Panel-GeneListAnnotated_01.pdf
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FIGURE 1 | Histomorphometric features of reticular fibers in uterine adenocarcinomas (uADC) and leiomyosarcomas (uLMS) in the 5 × 4-mm region of interest (ROI)
are very similar at the invasive tumor front (ITF). (A) Representative image of fiber segmentation in 5 × 4-mm ITF ROIs in uADC and uLMS. Reticular fibers are
highlighted in red. Scale bar represents 1 mm. (B) Comparison of morphometric parameters obtained after reticular fiber segmentation between uADC and uLMS
5 × 4-mm ITF ROIs. Fisher–Snedecor test and Student T-test were applied for statistical comparison. Mean, standard deviation (SD), p-Values, and significance
(∗ < 0.05) are shown. Total fibers, area of the core, and sum of the total area of the fibers were measured to calculate the density (number of fibers/mm2) and
percentage of the stained area (% SA). Area in μm2. Length and width in μm. (C) The same comparison as in B with more restrictive criteria for case selection.
included in any run. Library denaturation was performed
by first adding 2N NaOH, followed by addition of 2N
HCl. The PhiX was spiked in at 5% (concentration of 12.5
pM). Normalized libraries were sequenced by NGS. Four
demultiplexed FASTQ file per sample was retrieved from the
sequencer for data processing. HTG EdgeSeq host software
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FIGURE 2 | In-depth invasive tumor front (ITF) histomorphometric characterization of reticular fibers in uterine adenocarcinomas (uADC) and leiomyosarcomas
(uLMS) reveals a high degree of architectural similarity. Representative image of fiber segmentation in 1 × 1-mm tumor ROIs in uADC and uLMS. Comparison of
morphometric parameters obtained after reticular fiber segmentation between uADC and uLMS in panels (A) Intratumor 1 × 1-mm ROIs. (B) 1 × 1-mm myometrium
ROIs, and (C) 1 × 1-mm invasive tumor front (ITF) ROIs in uADC and uLMS. Reticular fibers are highlighted in red. Fisher–Snedecor test and Student T-test were
applied for statistical comparison. Mean, standard deviation (SD), p-Values, and significance (∗ < 0.05, ∗∗ < 0.01, ∗∗∗ < 0.001) are shown. Total fibers, area of the
core, and sum of the total area of fibers were measured to calculate the density (number of fibers/mm2) and percentage of stained area (% SA). Area in μm2. Length
and width in μm. Scale bars represent 250 μm.
FIGURE 3 | Distinct immune infiltrate distribution at the invasive tumor front (ITF) of uterine adenocarcinomas (uADC) and leiomyosarcomas (uLMS).
(A) Representative multiplex immunofluorescence images of approximately 5 × 4-mm regions of interest (ROIs) of an adenocarcinoma (uADC) (4 × 4) and a
leiomyosarcoma (uLMS) (5 × 3 mm). Color code as follows: DAPI (blue), CD20 (yellow), CD68 (green), CD8 (red), CD3 (orange), cytokeratin (cyan). (B) The mean of
the densities (number of cells/mm2) for each cell marker is shown for uADC and uLMS as well as the mean for the total cells and the total immune infiltrate.
Fisher–Snedecor test and Student T-test were applied for statistical comparison. P-values and significance (∗ < 0.05, ∗∗ < 0.01) for statistical comparison between
the means of uADC and uLMS are displayed. Scale bars represent 1 mm.
performed the alignment of the FASTQ files to the probe
list, then results were parsed, and the output obtained as a
read count matrix.
Raw count normalization and differential expression analysis
were calculated using DESeq2 R package (1.30.0). Sample outliers
were identified through variance stabilizing transformation.
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FIGURE 4 | Immune infiltrate characterization in 1 × 1-mm regions of interest (ROIs) in uterine adenocarcinomas (uADC) and leiomyosarcomas (uLMS).
(A) Representative multiplex images of 1 × 1-mm ROIs of intratumor, myometrium, and invasive tumor front (ITF) in uADC and uLMS. Color code as follows: DAPI
(blue), CD20 (yellow), CD68 (green), CD8 (red), CD3 (orange), cytokeratin (cyan). (B) The mean of the densities (number of cells/mm2) for each cell marker in each
region is shown for uADC and uLMS as well as the mean for the total cells and the total immune infiltrate. Fisher–Snedecor test and Student T-Test were applied for
statistical comparison. P-values and significance (∗ < 0.05, ∗∗ < 0.01, ∗∗∗ < 0.001) for statistical comparison between the means of intratumor, myometrium, and
ITF in uADC and uLMS are displayed. Scale bars represent 250 μm.
iDEP v0.922 was used for pathway analysis of normalized
expression values from RNA-Seq data (Ge et al., 2018).
Genome-Wide DNA Methylation Analysis
Total genomic DNA from 10-μm FFPE tissue sections of
microdissected ITF (uADC n = 24, uLMS n = 11) was
isolated using the AllPrep DNA/RNA FFPE Kit (Qiagen) and
following the manufacturer’s instructions. All DNA samples
were quantified by the fluorometric method using the Qubit
1× dsDNAHS (High-Sensitivity) Assay Kit (Thermo Fisher) and
were also checked for suitability for FFPE restoration following
the Infinium HD FFPE QC Assay (Illumina). DNA samples
(100–250 ng) that passed this quality control evaluation (uADC
n = 22, uLMS n = 9) were selected for bisulfite conversion
2http://ge-lab.org/idep/
using the EZ DNA Methylation kit (Zymo Research) and were
moved on to the FFPE Restore protocol (Illumina). The restoring
step was followed by Infinium HD FFPE methylation assay for
hybridization with InfiniumMethylationEPIC BeadChips, which
cover over 850,000 CpG sites along the human genome (Moran
et al., 2016). Whole-genome amplification and hybridization
were performed on the BeadChips followed by single-base
extension and analysis on a HiScan (Illumina) to assess the
cytosine methylation states. Image intensities were extracted
using GenomeStudio (V2011.1) Methylation module (1.9.0)
software from Illumina. Data quality control was assessed with
GenomeStudio and BeadArray Controls Reporter, based on the
internal control probes present on the array. The methylation
score of each CpG from samples that passed this quality control
(uADC n = 21, uLMS n = 9) was represented as β-value and
previously normalized for color bias adjustment, background
Frontiers in Cell and Developmental Biology | www.frontiersin.org 7 June 2021 | Volume 9 | Article 670185
Sanegre et al. Uterine-Myometrial Tumor Interface
level adjustment, and quantile normalization across arrays.
Probes and sample filtering involved a two-step process for
removing SNPs and unreliable β-values with a high detection
P-value > 0.01. After this filtering step, the remaining CpGs
were considered valid for the study. Non-parametric Wilcoxon
tests were applied to determine differentially methylated
CpGs (DMCpGs), which were considered significant with a
false discovery rate (FDR) below 5%. All statistical analyses
were performed in the R statistical environment (v.3.6.1).
The enrichment analysis of biological pathways for the
methylation profiles were evaluated by gene ontology (GO) using
GENECODIS (Tabas-Madrid et al., 2012).
RESULTS
Reticulin Fiber Scaffolding in uLMS and
uADC Is Similar
Several parameters of reticular fibers were assessed in 83.3%
of uADC and 81.8% of uLMS (20 of 24 uADC and 9 of 11
uLMS) (Supplementary Table 1). Interestingly, we found a high
degree of similarity between the 5 × 4 mm ROIs of uADC
and uLMS ITFs (Figures 1A,B); in fact, the only significant
differences observed in the cases studied were in area size and
deformity of the individual or meshwork fibers. However, we
next performed a more restrictive analysis, excluding one case of
each group based not only on algorithm quality control but on
subjective assessment by two independent scientists (Figure 1C).
In this case, we analyzed a more homogeneous sample group and
observed no significant size or shape-related differences between
the two tumor types. Large uADC ROIs with reticular fibers
occupying a higher proportion of stained area (higher %SA) than
uLMS were detected.
To test the robustness of the algorithm and assess the
representativeness of the 1-mm2 ROIs, we compared four ROIs
of 1 mm2 inside the 5 × 4 mm against four ROIs of 1 mm2
along the ITF for both uADC and uLMS.We found no significant
differences between ROIs (data not shown) and therefore
accepted the 1 × 1-mm areas as representative of the tumor,
myometrium, and selected field of ITF. Only regions meeting the
quality control parameters were included in the analysis. In total,
we compared n = 21 vs. n = 34 tumor ROIs, n = 39 vs. n = 24
myometrium ROIs, and n = 79 vs. n = 35 selected ITF ROIs
of uADC and uLMS, respectively (Supplementary Table 1). We
employed the same morphometric feature extraction procedure
as above, also performing the statistical Student test to compare
the mean of each acquired parameter by patient sample. In
the 1-mm2 ITF ROIs, the two tumor types presented a high
number of significantly different parameters (7/15) (Figure 2A).
uADC fibers appeared larger (area = 363.2 μm2 vs. 231.9 μm2)
and thicker (width = 16.21 μm vs. 13.6 μm) than in uLMS.
However, because uADC has significantly lower density of fibers
per μm2 (83.2 vs. 257.48 fibers/μm2) when compared to uLMS,
a smaller%SA of the tissue (2.73% vs. 5.84%) was shown.
Furthermore, uADC reticular fibers appeared smoother than the
wavy ones in uLMS, as indicated by the perimeter ratio (0.62
vs. 0.68). The higher values for vertices in uADC compared to
uLMS (6.04 vs. 5.56) suggest that reticular fibers have greater
branching in uADC. Finally, the fractal dimension revealed that
reticular fibers are more haphazardly arranged in uADC than in
uLMS (1.44 vs. 1.40). On the other hand, the myometrium of
uADC and uLMS displayed no significant differences in any of
the parameters studied (Figure 2B). Interestingly, only one shape
parameter (deformity) was significantly different between uADC
vs. uLMS (1932.4 vs. 1345.7) (Figure 2C). This observation is a
more reliable indication than the 5 × 4-mm ROI results of a high
degree of similarity between the reticular fiber scaffolding at the
ITF of uADC and uLMS.
To further characterize uLMS and uADC, the tumor,
myometrium, and selected ITF were compared against each other
for each tumor type. In contrast to the great similarity between
1-mm2 ROIs of different tissue areas in uLMS, we found that
uADC exhibited multiple differences when ITF was compared
against the tumor or myometrium (Table 1). There was higher
deposition of fibers, indicated by increased fiber density, in ITF
compared to tumor (307.10 vs. 83.28), leading to an increased
%SA (7.44 vs. 2.73). Reticular fibers at the uADC also appeared
thinner at ITF than in tumor (width = 13.03 vs. 16.22), were
linearized (aspect = 4.20 vs. 3.42), and presented less branching
(vertices = 5.68 vs. 6.04). Finally, when comparing 1-mm2 ROIs
of uADC ITF vs. myometrium, the fibers appeared bigger at the
ITF (area = 300.56 vs. 270.29), were thicker (width = 13.03 vs.
11.71) and longer (height = 48.36 vs. 43.02), and therefore had
a larger perimeter (88.25 vs. 72.83). In addition, the fibers at the
uADC ITF appeared less linearized (aspect = 4.20 vs. 4.15) and
branched (vertices = 5.68 vs. 5.54) (Table 1A). Interestingly, in
uLMS the only significant difference when comparing both ITF
and tumor vs. myometrium was fiber shape (shape ITF = 16.76
and tumor 21.05 vs. myometrium 11.04) (Table 1B).
Heterogeneous Immune Environment at
the ITF
In order to characterize immune infiltrate at the ITF, we used
six-color multiplex immunostaining (CD20, CD3, CD8, CD68,
CK, and DAPI) to estimate four different immune infiltrate
subpopulations in the same 5 × 4 mm ROIs of uADCs and
uLMS, used for reticular fiber analysis in sequential cuts in large
areas of uADCs and uLMS. The immune infiltrate was assessed
in 95.8% of uADC and in 81% of uLMS (23 out of 24 and
9 out of 11, respectively) (Supplementary Table 1). Overall,
approximately 1,595,232 cells were counted and evaluated by
digital pathology. Although the uLMS had a lower number of
total cells, the two tumor types displayed the same amount of total
immune infiltrate (956 for uADC and 991 for uLMS) (Figure 3).
However, we observed diverse immune cellular compositions
at the ITF, finding a clearly heterogeneous distribution of B
and T lymphocytes and macrophages in the different tumors
analyzed. Comparing the two tumors, B lymphocytes (CD20+)
appeared in lowest numbers out of the total immune population,
being statistically smaller in uLMS, while there was a significant
increase in macrophages, which represented the highest immune
population in uLMS. Conversely, T lymphocytes (CD3+)
emerged as the predominant immune infiltrate in uADC. The
relative frequency of CD20, CD3, CD8, and CD68-positive cells
within each tumor reflected that uADCs and uLMS exhibited
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TABLE 1 | Heterogeneous architecture of reticular fibers between 1 × 1-mm regions of interest (ROIs) of tumor, myometrium, and invasive tumor front (ITF) within uterine
adenocarcinomas (uADC).
A B
Myometrium ITF Myometrium ITF
Mean p value Mean p value
Fibers 263,94 246,26 0,397 Fibers 245,38 257,15 0,809
Area core (mm2) 0,97 0,96 0,020 * Area core (mm2) 0,92 0,96 0,531
Density 270,29 307,10 0,526 Density 277,25 268,95 0,888
Fiber total area (mm2) 0,05 0,07 0,060 Fiber total area (mm2) 0,05 0,06 0,180
% SA 5,97 7,44 0,042 * % SA 5,94 6,47 0,714
Area 227,58 300,55 0,021 * Area 215,28 248,33 0,175
Width 11,71 13,02 0,030 * Width 11,69 12,34 0,640
Height 43,02 48,35 0,013 * Height 42,57 46,73 0,072
Angle −50,86 −50,84 0,994 Angle −55,72 −48,86 0,094
Roundness 0,13 0,13 0,010 * Roundness 0,14 0,13 0,064
Aspect 4,15 4,20 0,858 Aspect 4,63 4,44 0,798
Perimeter ratio 0,67 0,66 0,336 Perimeter ratio 0,68 0,68 0,979
Perimeter 72,83 88,24 0,022 * Perimeter 67,34 83,88 0,056
Deformity 1193,94 1932,43 0,009 ** Deformity 1018,52 1345,71 0,096
Shape 24,14 21,02 0,645 Shape 11,04 16,76 0,027 *
Vertices 5,54 5,67 0,042 * Vertices 5,60 5,63 0,839
Fractal dimension 1,39 1,39 0,838 Fractal dimension 1,40 1,39 0,742
Tumor ITF Tumor ITF
Mean p value Mean p value
Fibers 79,07 246,27 0,000 *** Fibers 248,74 257,15 0,750
Area core (mm2) 0,93 0,96 0,468 Area core (mm2) 0,97 0,96 0,396
Density 83,28 307,1 0,007 * Density 257,48 268,95 0,690
Fiber total area (mm2) 0,02 0,07 0,000 *** Fiber total area (mm2) 0,05 0,06 0,357
% SA 2,73 7,44 0,000 *** % SA 5,84 6,47 0,339
Area 363,23 300,56 0,109 Area 231,91 248,33 0,530
Width 16,21 13,03 0,000 *** Width 13,65 12,34 0,283
Height 49,54 48,36 0,718 Height 44,49 46,73 0,426
Angle −50,50 −50,84 0,867 Angle −49,74 −48,86 0,647
Roundness 0,13 0,13 0,228 Roundness 0,14 0,13 0,343
Aspect 3,42 4,2 0,011 * Aspect 3,82 4,44 0,072
Perimeter ratio 0,63 0,66 0,078 Perimeter ratio 0,68 0,68 0,651
Perimeter 106,88 88,25 0,241 Perimeter 78,03 83,88 0,524
Deformity 2156,74 1932,44 0,554 Deformity 1579,96 1345,71 0,425
Shape 13,10 21,02 0,140 Shape 21,05 16,76 0,285
Vertices 6,041 5,68 0,000 *** Vertices 5,57 5,63 0,482
Fractal dimension 1,45 1,39 0,000 *** Fractal dimension 1,40 1,39 0,306
Myometrium Tumor Myometrium Tumor
Mean p value Mean p value
Fibers 263,94 79,07 0,000 *** Fibers 245,38 248,74 0,941
Area core (mm2) 0,97 0,93 0,258 Area core (mm2) 0,92 0,97 0,414
Density 270,28 83,28 0,000 *** Density 277,25 257,48 0,714
Fiber total area (mm2) 0,05 0,02 0,000 *** Fiber total area (mm2) 0,05 0,05 0,541
% SA 5,97 2,73 0,001 ** % SA 5,94 5,84 0,944
Area 227,58 363,23 0,001 ** Area 215,28 231,91 0,566
Width 11,71 16,21 0,000 *** Width 11,69 13,65 0,182
Height 43,02 49,53 0,066 Height 42,57 44,49 0,574
(Continued)
Frontiers in Cell and Developmental Biology | www.frontiersin.org 9 June 2021 | Volume 9 | Article 670185
Sanegre et al. Uterine-Myometrial Tumor Interface
TABLE 1 | Continued
A B
Myometrium Tumor Myometrium Tumor
Mean p value Mean p value
Angle −50,86 −50,50 0,872 Angle −55,72 −49,74 0,083
Roundness 0,14 0,13 0,458 Roundness 0,14 0,14 0,441
Aspect 4,15 3,42 0,054 Aspect 4,63 3,82 0,207
Perimeter ratio 0,66 0,63 0,020 * Perimeter ratio 0,68 0,68 0,825
Perimeter 72,83 106,88 0,056 Perimeter 67,34 78,03 0,139
Deformity 1193,94 2156,73 0,008 ** Deformity 1018,52 1579,96 0,085
Shape 24,14 13,10 0,186 Shape 11,04 21,05 0,040 *
Vertices 5,54 6,04 0,000 *** Vertices 5,60 5,57 0,784
Fractal dimension 1,39 1,44 0,003 ** Fractal dimension 1,40 1,40 0,777
(A) Comparison of morphometric parameters obtained after reticular fiber segmentation between myometrium and ITF, tumor and ITF, and myometrium and tumor in
1 × 1-mm uADC ROIs. (B) Comparison of morphometric parameters obtained after reticular fiber segmentation between myometrium and ITF, tumor and ITF, and
myometrium and tumor in 1 × 1-mm leiomyosarcoma (uLMS) ROIs. Fisher–Snedecor test and Student T-test were applied for statistical comparison. Mean, standard
deviation (SD), p values, and significance (* < 0.05, ** < 0.01, and *** < 0.001) are shown. Total fibers, area of the core, and sum of the total area of the fibers were
measured to calculate the density (number of fibers/mm2) and percentage of stained area (% SA). Area in μm2. Length and width in μm.
cellular heterogeneity regarding immune distribution, whereas
the total amount of infiltrate remained the same in 5 × 4-mm
ITF (Figure 3).
Aiming for a more thorough characterization of the immune
infiltrate, and given the heterogeneity observed, we proceeded
to analyze the 1 × 1-mm ROIs, dividing the regions between
tumor, myometrium, and ITF, choosing the same regions
used for reticular fiber analysis (Supplementary Figure 1).
After statistical comparison, we observed that uLMS had less
total immune infiltrate than uADC (860 cells/mm2 vs. 276
cells/mm2) in the tumor areas, and in fact, fewer overall cells
with markers were identified in uLMS (Figure 4); however,
only CD8 became statistically smaller (132 cells/mm2 vs. 12
cells/mm2). This observation suggests that uLMS tumor areas
are colder, or less abundant in terms of immune infiltrate, than
uADC (Figure 4). Regarding uADC and uLMS myometrium,
no significant differences in distribution of CD20-, CD3-, CD8-,
and CD68-positive cells were found between the two tumor
types, as expected, with a low number of total cells in the
myometrium near uLMS (Figure 4). However, the 1 × 1-mm
ITF regions displayed significant differences between CD20-,
CD3-, and CD8-positive cells per mm2, being higher in uADC.
The macrophage remained the most abundant existing cells in
both ITF tumors (Figure 4). Interestingly, the 1-mm2 ITF ROIs
results were more accurate than 5 × 4-mm ITF. The CD20
population still remained the lowest of all in both tumors, being
significantly smaller in uLMS.While CD68-positive cells were the
predominant population in uLMS, CD3 was the highest in uADC
and again significantly different compared to uLMS.
Transcriptional Profiling Reveals a
Possible Role for Antimicrobial Peptides
in Immune Response at the ITF of uADC
Differential gene expression analyses revealed statistically
significant upregulation of 142 genes and downregulation of 97
genes when comparing uADC (n = 19) vs. uLMS ITF (n = 11)
(Supplementary Table 1). A slight upregulation of T cell and
B cell markers was observed in uADC ITF, but no differences
were detected in myeloid expression markers (Figure 5A) in
accordance with the multiplex immunofluorescence findings.
Parametric analysis of gene-set enrichment using GO showed
the activation of several biological processes related to cell
adhesion, epithelial cell development, and kidney morphogenesis
in uADC ITF, likely resulting from their intrinsic tumor
morphology (Figure 5B). Indeed, uADC ITF showed increased
expression of E-cadherin, EPCAM, and several keratins and
integrins (Figure 5C).
Interestingly, antimicrobial humoral response appeared to
be activated in uADC ITF. By querying the curated reactome
database, upregulation of antimicrobial peptides was also
observed, along with innate immune response and neutrophil
degranulation (Figure 5D). ECM proteoglycans seemed to
be upregulated in the uLMS ITF, as expected given their
mesenchymal phenotype.
Genome-Wide DNA Methylation Analysis
Identifies an Epigenetic Signature of ITF
Related to Cell Adhesion and
Extracellular Matrix
The DNA methylation profile of the primary ITF was compared
in uADC (n = 21) and uLMS (n = 9) using the Infinium
MethylationEPIC array (850 K) (Figure 6A). The scatter plot
of this epigenomic comparison revealed that the ITFs of both
tumor types share a similar general DNA methylation pattern
(R2 = 0.946) (Figure 6B). In this sense, most of the 665,840
valid CpGs analyzed had similar DNA methylation levels, while
a small proportion of CpGs (3.5%, 23,296 CpGs) showed
significant differences (p < 0.05; FDR < 5%) between uADC
and uLMS. These differentially methylated CpGs (DMCpGs)
were distributed in several regions of the genome (Figure 6C),
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including CpG islands (CGIs) and promoters. We found an
epigenetic signature of 2,971 DMCpGs (corresponding to 1,253
genes) located in CGIs of promoters, which were able to
differentiate the ITF of uADC and uLMS (Figure 7A). Of note,
the GO analysis of this epigenetic signature revealed enrichment
of differentially methylated genes between uADC and uLMS
related to cell adhesion and ECM organization pathways, among
others. However, no evident enrichment of immune response
pathways was detected (Figure 7B).
Gene Expression Profiling and DNA
Methylation Identify a 20-Gene
Epigenetic Signature Characteristic of
ITF
As hypermethylation of promoters has been demonstrated
to induce gene silencing in several tumor types, including
uterine neoplasms (Zhang et al., 2018), we decided to
evaluate the association between the gene expression and
methylation profiling of promoter CGIs previously found in
the TIF of primary uterine uADC and uLMS. We found
20 genes whose methylation status correlated with significant
changes in gene expression (Figure 8A and Supplementary
Table 3); specifically, nine hypermethylated genes showed
downregulated gene expression, while 11 hypomethylated genes
were overexpressed. Of note, these 20 genes (corresponding to 58
CpGs) represent a signature able to clearly differentiate the ITF
of primary uterine uADC and uLMS (Figure 8B). Importantly,
some of the genes of this signature are related to immune system,
cell adhesion, and tumor stroma.
DISCUSSION
In the uterus, uADC and uLMS account for a significant
proportion of malignant tumors associated with distant
metastasis. These tumors possess distinct morphological
and molecular features, and also a differing cell of origin.
However, both occur in the uterus, and each of them invades
the myometrium as the initial step for tumor progression.
Although dissimilar in many aspects, it is feasible that they share
some adaptive responses while invading the myometrium, or
alternatively, they could produce a similar response to tumor
invasion in the myometrium.
The process of stromatogenesis refers to the formation of new
stroma in the active sites of tumor invasion and metastasis. It is
proposed that the formation of this new stroma is generated and
governed by the interplay between tumor cells and the complicity
of adjacent activated fibroblasts. This new stroma disrupts the
normal structures of the ECM and its continuity and favors
easy penetration by tumor cells, thus helping their migration
and immune cell infiltration among other cells (Giatromanolaki
et al., 2007; Horrée et al., 2007; Bremnes et al., 2011). The ECM
composition and spatial organization of collagen fibers in the
newly formed stroma is decisive not only for development of
several neoplasia but for tumor prognosis (Kondo, 2011; Acerbi
et al., 2015; Devendra et al., 2018; Xu et al., 2019). In fact, like
type I collagen, reticulin distribution is increased inmany cancers
such as head and neck squamous cell cancer, breast, pancreas, and
colorectal cancer (Nissen et al., 2019) and increases proliferation,
migration, and metastasis in pancreatic and glioblastoma cancer
cells as well as in invasive prostate cancer (Chintala et al., 1996;
Menke et al., 2001; Kanematsu et al., 2004). Thus, in-depth
characterization of morphometric features of reticular fibers
(collagen type III) in invasive tumors could provide advanced
insight into mechanisms underlying the invasion and galvanize
targeted strategies for precision medicine (Kanner et al., 2013;
Walke and Bhagat, 2017).
Although several aspects of the ITF have been characterized
in other types of tumors, comparison between them is
very complicated due to differing quantification methods.
Furthermore, the exact size of the true invasion front is also
under debate (Horrée et al., 2007) and little is known about the
histomorphometry of the fibers at the ITF of uADC and uLMS.
When analyzing the 5 × 4-mm ITF areas of uADC and uLMS,
we found very few significant differences between morphometric
parameters, indicating a striking similarity between the ITF of
the two tumor types. In a restrictive analysis, choosing a uADC
sample group with a more homogeneous architecture (based on
subjective criteria), all the significant differences disappeared,
suggesting that an inclusive analysis reflects the architectural
heterogeneity of the uADC tumors. We also circumvented the
issue of variable tissue amounts when analyzing 5 × 4-mm ITF
ROIs by increasing the magnification of the ROIs to 1 mm2
within the previously studied 5 × 4-mm ROIs in which we
ensured 50% each of the tumor and myometrium. After the
necessary controls, we found that the area of the fibers in the
1-mm2 ITF was no longer significantly different between uADC
and uLMS, but the differences in deformity remained, indicating
the potential value of this parameter as a differential characteristic
between the two types of tumors. We hypothesized that the area
of the fibers in the 5 × 4-mm areas could vary due to an uneven
contribution of the tumor to the analysis, given that the area
was no longer different in the 1-mm2 ITF ROIs. The algorithm
showed notably high sensitivity when measuring morphometric
parameters, since in the 1-mm2 areas of myometrium we did
not observe any significant differences between the two tumors,
as expected. However, the large number of differences observed
between 1-mm2 areas of pure tumor tissue reflects the ability to
detect differences between negligible reticular fiber features of the
tumors under subjective criteria.
At a microscopic level, ROIs of 1 mm2 were sufficient
for comparison of reticular fiber morphometric parameters
between the tumor, myometrium, and ITF of uADC and
uLMS. Furthermore, 1-mm2 ROIs allowed us to characterize the
microarchitecture of the reticular fibers within the same type of
tumor. Interestingly, comparisons between tumor, myometrium,
and ITF in uLMS revealed a high degree of similarity and
little disruption of tissue architecture. Conversely, in uADC
we observed a very high number of significantly different
morphometric features comparing the abovementioned ROIs
(Table 1), suggesting that continuity of ECM architecture is
much more disrupted in uADC than uLMS tumors. Regardless
of statistical difference, observing the mean of morphometric
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FIGURE 5 | Transcriptomic profiling of invasive tumor front (ITF) in uterine adenocarcinomas (uADC) and leiomyosarcomas (uLMS). (A) RNA-seq expression levels (as
counts per million, log2 scale) of cellular markers for macrophages (CD68), T cells (CD3 and CD8), and B lymphocytes (CD20). Slight upregulation of B and T cell
markers is observed. (B) Parametric analysis of gene-set enrichment using the Gene Ontology biological process dataset. Red and blue indicate activated and
suppressed pathways, respectively. (C) RNA-seq expression levels (as counts per million, log2 scale) of genes related to cell adhesion and epithelial cell
development. Increased gene expression in uADC vs. uLMS was significant in all the markers. (D) Parametric analysis of gene-set enrichment using the curated
reactome dataset reveals a possible role for antimicrobial peptides in immune response of uADC. Red and blue indicate activated and suppressed pathways,
respectively.
parameters at the ITF of uADC, we found that almost all values
fell within the range of myometrium and tumor means, except
for density (along with increased%SA) and aspect (linearization)
of fibers (Table 1). Since the areas were carefully chosen to
represent 50% each of myometrium and tumor components,
we hypothesized that most changes observed at the uADC ITF
could be attributable to the contribution of adjacent tissue.
However, we cannot exclude the possibility of orchestrated ECM
remodeling by tumor and non-tumoral cells to favor tumor
cell migration (Giatromanolaki et al., 2007; Horrée et al., 2007;
Bremnes et al., 2011). In fact, during tumor progression, cancer-
associated fibroblasts are key players in dysregulated collagen
turnover, leading to tumor fibrosis as evidenced by increased
collagen depositions in the immediate periphery of the tumor
(Pankova et al., 2016). Consistent with our results, we observed
an increase of fiber density at the uADC ITF compared to
tumor. In addition, the collagens are often cross-linked and
linearized leading to stiffening of the tissue in several tumors
(Nissen et al., 2019), which we also observed in uADC ITF as
displayed by a significantly longer appearance (linearization) of
the reticular fibers at the uADC ITF. ECM stiffening could in turn
elicit behavioral effects on surrounding tumor cells regarding
cell proliferation, differentiation, gene expression, migration,
invasion, metastasis, and survival, all hallmarks of cancer (Pickup
et al., 2014), and which correlate with worse patient outcomes
patient (Leeming et al., 2011; Kehlet et al., 2016). Nevertheless,
there are still several features of the fiber topology to take
into account for future studies that would require smaller
regions, such as analysis of fiber orientation with respect to the
tumor–myometrium boundary, which would provide additional
value for prognosis (Acerbi et al., 2015; Conklin et al., 2011;
Xu et al., 2019).
Through multiplex cellular analyses, we could demonstrate
that the uADC ITF contains a heterogeneous immune
environment compared to the one in LSM. We found variance
between different CD8 + T cell and macrophage subpopulations
of different ITF in uADC and LSM. This suggests diverse myeloid
and lymphocyte compositions of ITF immune environments,
with CD8 + T cell and macrophage density possibly influenced
by the presence of certain ECM components, such as collagens
fibers, which could prevent interactions with other immune cells.
It has been shown that the reciprocal interaction between the
ECM and tumor and non-tumor cells such as myofibroblasts
determines recruitment, activation, and reprogramming of
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FIGURE 6 | Genome-wide DNA methylation analysis in invasive tumor front (ITF) of primary uterine adenocarcinomas (uADC) and leiomyosarcomas (uLMS) shows a
small proportion of CpGs with differential methylation pattern. (A) Schematic flowchart used to identify differentially methylated CpGs (DMCpGs) in primary ITF
between uADC and uLMS. (B) Scatter plot representing mean normalized levels of DNA methylation (β-values) in primary ITF of uADC and uLMS. (C) Genomic
distribution of 23,296 differentially methylated CpGs (DMCpGs) in primary ITF of uADC and uLMS, in relation to their respective location regarding CpG context and
gene region.
stromal, inflammatory, and immune cells (Sanegre et al., 2020).
Despite the great similarity of reticulin scaffolding at the ITF of
uADC and uLMS, we observed a differential immune infiltrate
pattern, as informed by CD20, CD3, and CD8 markers. We
thus cannot attribute a direct effect of reticulin architecture on
the immune infiltrate composition right at the ITF. However,
there could be a relationship between the morphometry of
reticular fibers and the total amount of infiltrate, since the
immune population is the same in both tumor types. A dense
architectural barrier can be imposed not only by reticular fibers
but also by ECM elements such as other collagens, hyaluronic
acid, and laminins. Whereas high molecular weight hyaluronic
acid provides structural integrity and suppresses the immune
response by increasing regulatory T cell activity, laminins prevent
transmigration and polarize leukocytes (Bollyky et al., 2009;
Chanmee et al., 2016; Simon and Bromberg, 2017). ECM
remodeling enzymes such as metalloproteinases, matrikines,
and versicans act as cytokines and chemokines promoting IL
expression and T cell chemoattractants, polarizing and activating
the immune cells (Thomas et al., 2007; Hope et al., 2016). In
fact, although an upregulation of collagen genes in uLMS tumors
can be observed, it is still not clear whether these genes are
responsible for immune density distribution. Another plausible
explanation for leukocyte accumulation at the ITF of uADC
could be that reticulin morphometric description suggests that
uADC tumor areas seem stiffer than uLMS tumors, as indicated
by the larger area and width and greater branching and fractal
dimension of the fibers (although fewer fibers can be counted).
Stiffer tumors could lead to a physical barrier, thus increasing the
leukocyte concentration at the ITF. In addition, ECM stiffness
can induce chromosomal rearrangements and transcriptional
changes in several diseases (Simi et al., 2018; López-Carrasco
et al., 2020) and many stiffness-sensitive genes may respond to
stiffness in non-linear ways (Darnell et al., 2018).
Transcriptomic profiling of the ITF of uADC and uLMS
suggests that activated neutrophils secreting antimicrobial
peptides (AMP) may play a role in the immune response
to oncogenesis in the context of endometrial tumors. Indeed,
antimicrobial humoral response seems to be inactivated in uLMS,
in stark contrast to uADC, in which there is an upregulation
of this signature. AMPs have been described as important
actors in angiogenesis and modulation of the immune response,
via stimulation of chemokines and chemotaxis of leukocytes,
and may also exert cytotoxic activity against tumor cells (Al-
Rayahi and Sanyi, 2015; Jin and Weinberg, 2019). In fact,
LCN2, one of the top upregulated genes in the ITF of uADCs
(Supplementary Table 2), codes for neutrophil gelatinase-
associated lipocalin, which has been reported to be associated
with aggressive features of endometrial uADC (Mannelqvist et al.,
2012; Cymbaluk-PA Oska et al., 2019) but is also described
as an invasiveness and metastasis suppressor in other contexts
(Lee et al., 2006; Lim et al., 2007; Tong et al., 2008; Santiago-
Sánchez et al., 2020). Another highly upregulated antimicrobial
peptide, DEFB1 (Supplementary Table 2), belongs to a family
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FIGURE 7 | Identification of differential DNA methylation signature of promoter CGIs in invasive tumor front (ITF) of primary uterine adenocarcinomas (uADC) and
leiomyosarcomas (uLMS). (A) Supervised hierarchical clustering of the most variable CpGs (2,971 CpGs and 1,253 genes; FDR < 5%) from island and promoter
regions between the primary ITF of uADC and uLMS. (B) Gene ontology (GO) analysis of the biological process categories for the 1,253 differentially methylated
genes at CpG island and promoters between the primary ITF of uADC and uLMS.
of cytotoxic peptides made by neutrophils. This gene has
recently been identified as a chromosome 8p tumor-suppressor
gene, downregulated in several malignancies such as salivary
gland tumors, oral squamous cell carcinoma, and colon and
liver cancer (Álvarez et al., 2018; Sun et al., 2019). Loss of
orthologous murine defense-1 in mice enhances nickel sulfate-
induced uLMS and causes mouse kidney cells to exhibit increased
susceptibility to HPV-16 E6/7-induced neoplastic transformation
(Sun et al., 2019). DEFB1 also induces formation of neutrophil
extracellular traps (NETs) (Álvarez et al., 2018), mesh-like
structures composed of cytosolic and granule proteins which are
assembled on a scaffold of decondensed chromatin fibers in a
process termed NETosis, which has been proposed to protect
tumor cells from T cell- or natural killer (NK) cell-mediated
toxicity (Teijeira et al., 2020). This should be further studied by
developing a specific antibody panel to visualize and measure
NET formation in tissue. Other upregulated antimicrobial genes
such as the chemokine CXCL3 could contribute to recruitment
of neutrophils at the ITF. Altogether, it is tempting to speculate
that impaired antimicrobial humoral response could contribute
to local or distant spread of uterine uLMS.
Epigenomic analysis showed a generally similar methylation
pattern in the ITF of uADC and uLMS. However, when
we focused our analysis on CGI promoters, we observed a
different methylation profile in the ITF of the two tumor types.
Interestingly, part of these differentially methylated genes was
involved in biological processes related to cell adhesion and
ECM organization. Of note, both biological pathways play a
major role in invasion and migration of several types of tumors,
including uterine neoplasms (Abal et al., 2007; Yadav et al.,
2020), suggesting that epigenetic disruption of these pathways
could influence the metastatic properties of uADC and uLMS.
In addition, combining transcriptomic and epigenomic analysis,
we observed an association between the methylation status of
CGI promoters and expression in a set of 20 genes, implying
epigenetic regulation of these genes in ITF. Importantly, this
20-gene epigenetic signature was able to clearly differentiate
between ITF of uADC and uLMS. One of these genes was
ITGB3, an integrin involved in cell adhesion and ECM whose
deregulation is associated with cancer metastasis (Langsenlehner
et al., 2006; Hu et al., 2018). Another epigenetically regulated gene
identified in this signature was CXCL16, a chemokine-derived
peptide implicated in antimicrobial and antitumoral response
(Valdivia-Silva et al., 2015). Cancer patients with high levels of
CXCL16 expression have shown more elevated levels of CD4(+)
and CD8(+) tumor-infiltrating lymphocytes and NK, leading
to improved disease prognosis (Hojo et al., 2007; Valdivia-Silva
et al., 2015). However, this chemokine can also induce invasion
and metastasis via several mechanisms, such as the recruitment
of mesenchymal stem cells into the tumor (Jung et al., 2013). In
addition, CXCL16 contributes to ectopic endometrial stromal cell
migration and invasion (Peng et al., 2019).We also detected other
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FIGURE 8 | Invasive tumor front (ITF) is defined by a 20-gene expression signature, under epigenetic regulation, in primary uterine adenocarcinomas (uADC) and
leiomyosarcomas (uLMS). (A) Venn diagrams showing the differentially methylated and differentially expressed genes between the primary ITF of uADC and uLMS.
The names of the nine hypermethylated and downregulated genes in uADC compared to uLMS are indicated in red, and those of the 11 hypomethylated and
upregulated genes in uADC compared to uLMS are represented in green. (B) Supervised hierarchical clustering of the CpGs from promoter CGIs (corresponding to
20 genes) whose methylation status correlated with significant changes in gene expression. β-Values represent the normalized levels of DNA methylation.
epigenetically regulated genes in this signature, including CD70,
IRAK, IL20RA, THBD, TACSTD2, andMST1R, with implications
related to the tumor immune microenvironment (Jain et al.,
2014; Rossi et al., 2014; Babicky et al., 2019; Gu et al., 2020;
Kumar et al., 2020; Gao et al., 2021). In our study, TACSTD2
was overexpressed and hypomethylated in the ITF of uADC
in contrast to uLMS. Interestingly, other studies have found
highly expressed TACSTD2 in aggressive endometrial carcinomas
associated with tumor invasion (Bignotti et al., 2011), and it has
been suggested as an attractive target for cancer immunotherapy
in biologically aggressive endometrial carcinomas (Bignotti et al.,
2012). Collectively, these data indicate that although the ITFs
of uADC and uLMS have a similar global methylation status,
there are also some significant epigenetic differences that could
influence the invasive, migration, and tumor microenvironment
properties of the two types of uterine neoplasms.
CONCLUSION
In conclusion, our results demonstrate that uADC and uLMS
share several morphometric and molecular features at the
interface between tumor cells and myometrium, but also an
intertumoral heterogeneity. There was a high degree of similarity
between tumor and ITF in reticulin scaffolding, macrophage
infiltration, and global DNA methylation pattern. However,
uLMS had fewer T and B lymphocytes; additionally, neutrophil
degranulation releasing antimicrobial peptides was observed in
uADCs, but not in uLMS. Furthermore, gene expression profiling
and DNA methylation identified a 20-gene epigenetic signature
characteristic of ITF. It seems that the two tumors exhibit certain
remarkable similarities when invading the myometrium despite
being different neoplasms with profound morphologic and
molecular differences, and originating from different precursor
cells. These findings open up the possibility of investigating
common therapeutic strategies based on these similarities in
the ITF microenvironment. The results reported in this article
have various potential clinical implications. The characteristics
of the tumor microenvironment and immune surveillance in
these two types of tumor suggest that targeting non-cancer
cells, or mediators of their communication, may be efficient
across different tumor types and could also complement other
therapies. Moreover, tumor microenvironment features may
provide insight into the mechanisms underlying the failure of
previously effective anticancer drugs.
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Supplementary Figure 1 | In-depth characterization of the invasive tumor front
(ITF) in uterine adenocarcinomas (uADC) and leiomyosarcomas (uLMS). A tumor
biopsy from an adenocarcinoma (uADC) is shown. (A) Schematic pipeline for
tumor ITF area selection for histomorphometric analysis, immune infiltrate,
transcriptomics and methylation analysis. Scale bars represent 250 μm. (B)
Selection from a 5 × 4 mm region of interest (ROI) of 1 × 1 mm ROIs of invasive
tumor front (ITF), myometrium and tumor. The same criteria were applied for uADC
and uLMS. For 5 × 4 mm image, scale bar represents 1 mm. For 1 × 1 mm
images, scale bars represent 250 μm.
Supplementary Table 1 | Case selection and regions of interest (ROIs) used in
each characterization of uterine adenocarcinomas (uADC) and leiomyosarcomas
(uLMS). Case identification is shown by tumor ID. The percentage of
tumor/myometrium tissues for genomic and epigenetic profiling was evaluated in
H&E stained samples. The total numbers of ROIs and tumors used for all the
studies are shown. Invasive tumor front (ITF).
Supplementary Table 2 | Transcript expression profile of the invasive tumor
front (ITF) in uterine adenocarcinomas (uADC) and leiomyosarcomas
(uLMS).
Supplementary Table 3 | DNA methylation levels at promoter CGIs of 20
differentially methylated and differentially expressed genes associated with primary
ITF in uterine adenocarcinomas (uADC) and leiomyosarcomas (uLMS).
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